Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients After Chemoradiation: Its Clinical Implications

BACKGROUND: We have limited knowledge of the geographic distribution of resistant EAC in the resected specimen and its clinical importance can be enormous. METHOD: We selected patients with baseline stage III EAC who had chemoradiation followed by surgery, and had residual EAC (resistant cases only)...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncology
Auteurs principaux: Neishaboori, Nastaran, Wadhwa, Roopma, Nogueras-González, Graciela M., Elimova, Elena, Shiozaki, Hironori, Sudo, Kazuki, Charalampakis, Nikolaos, Hiremath, Adarsh, Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Blum, Mariela A., Rogers, Jane E., Garris, Jeana L., Rice, David C., Komaki, Ritsuko, Swisher, Stephen G., Skinner, Heath D., Hofstetter, Wayne L., Ajani, Jaffer A.
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4498973/
https://ncbi.nlm.nih.gov/pubmed/25765719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000371889
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires